Lobe Sciences Ltd
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The … Read more
Market Cap & Net Worth: Lobe Sciences Ltd (LOBEF)
Lobe Sciences Ltd (OTCQB:LOBEF) has a market capitalization of $646.77K ($646.77K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #38020 globally and #12383 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lobe Sciences Ltd's stock price $0.00 by its total outstanding shares 269487134 (269.49 Million).
Lobe Sciences Ltd Market Cap History: 2019 to 2025
Lobe Sciences Ltd's market capitalization history from 2019 to 2025. Data shows change from $102.84 Million to $646.77K (-61.83% CAGR).
Lobe Sciences Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lobe Sciences Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
25.52x
Lobe Sciences Ltd's market cap is 25.52 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $102.84 Million | $773.79K | -$754.43K | 132.90x | N/A |
| 2020 | $164.93 Million | $884.84K | -$3.44 Million | 186.39x | N/A |
| 2023 | $323.38K | $840.53K | -$4.71 Million | 0.38x | N/A |
| 2024 | $3.48 Million | $136.21K | -$4.42 Million | 25.52x | N/A |
Competitor Companies of LOBEF by Market Capitalization
Companies near Lobe Sciences Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Lobe Sciences Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Lobe Sciences Ltd Historical Marketcap From 2019 to 2025
Between 2019 and today, Lobe Sciences Ltd's market cap moved from $102.84 Million to $ 646.77K, with a yearly change of -61.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $646.77K | -81.40% |
| 2024 | $3.48 Million | +975.00% |
| 2023 | $323.38K | -96.19% |
| 2022 | $8.49 Million | -75.00% |
| 2021 | $33.96 Million | -79.41% |
| 2020 | $164.93 Million | +60.38% |
| 2019 | $102.84 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Lobe Sciences Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $646.77K USD |
| MoneyControl | $646.77K USD |
| MarketWatch | $646.77K USD |
| marketcap.company | $646.77K USD |
| Reuters | $646.77K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.